Drugmaker GSK said Wednesday it would invest $30 billion in U.S. research and development and supply chain infrastructure ...

Merck and AstraZeneca say the United Kingdom is not spending enough on medicines, but experts say it’s a symptom of ...

India's vast generic drug production and cost efficiency offer an immediate buffer to US President Donald Trump's 100% tariff on branded and patented pharmaceutical products..India’s pharma index and ...

Whether people pay more for weight loss drugs and other medications may hinge on how lenient Trump is with exemptions.

A report analyzed the growth potential of the global radioactive drug industry and opportunities for domestic companies. Groth Research published a report on the 29th that focused on the industrial ...

Power. Lies. Corruption. David Tennant & Robert Carlyle lead an all-star cast in this explosive true crime drama about the ...

A $600,000 allocation from Oklahoma City's economic development fund is being sought for construction of a new $46.7 million medical research lab.

Since coming into power last year, Rachel Reeves and Keir Starmer have consistently stressed the importance of the life ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem ...

Pharma R&D faces rising trial complexity, high costs, and patient and investigator shortages, driving the need for adaptive models and data-driven strategies to speed therapies to market.

Sai Life Sciences plans to invest ₹700 crore this year to expand its discovery, process research, and peptide capabilities, aiming to capitalise on rising pharma outsourcing trends. The company ...